Vertex Pharmaceuticals has discontinued its collaborative cystic fibrosis (CF) program with Moderna, citing concerns related to lung inflammation. The decision marks a significant shift for both companies, which had aimed to develop a new treatment option for CF patients not currently served by existing therapies. The halted program was designed to address the needs of…
In this video, we’re looking at five publicly traded companies based right here in the state and how they stack up by market value.
